Innovating Works

Geneton

Desconocido
ADDIT-CE: Alzheimer's Disease Diagnostics Innovation and Translation to Clinical Practice in Central Europe GENETON S.R.O. participó en un HORIZON EUROPE: HORIZON-WIDERA-2022-ACCESS-04 More than 55 million people worldwide suffer from dementia. Alzheimer disease (AD) is the main cause of this fatal disorder, without any eff...
2022-11-10 - 2026-12-31 | Financiado
ALPACA: ALgorithms for PAngenome Computational Analysis GENETON S.R.O. participó en un H2020: H2020-MSCA-ITN-2020 Genomes are strings over the letters A,C,G,T, which represent nucleotides, the building blocks of DNA. In view of ultra-large amounts of gen...
2020-08-27 - 2024-12-31 | Financiado
InterTAU: Integrative structural biology of pathological tau protein an appealing therapeutic target for Alzh... GENETON S.R.O. participó en un H2020: H2020-MSCA-RISE-2019 There is an enormous and unmet medical need to find efficient methods of prevention, diagnosis and disease- modifying therapies for neurodeg...
2019-11-27 - 2025-06-30 | Financiado
PANGAIA: Pan genome Graph Algorithms and Data Integration GENETON S.R.O. participó en un H2020: H2020-MSCA-RISE-2019 Genomes are strings over the letters A,C,G,T, which represent nucleotides, the building blocks of DNA. In view of ultra-large amounts of gen...
2019-10-04 - 2025-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.